首页 | 本学科首页   官方微博 | 高级检索  
检索        

MVP与EP方案治疗晚期非小细胞肺癌疗效对比观察
引用本文:柳影,鲍慧铮,马丽霞.MVP与EP方案治疗晚期非小细胞肺癌疗效对比观察[J].实用肿瘤学杂志,2003,17(2):135-137.
作者姓名:柳影  鲍慧铮  马丽霞
作者单位:吉林省肿瘤医院化疗一科,长春,130012
摘    要:目的观察比较MVP方案EP方案两种不同化疗方案治疗晚期非小细胞肺癌(NSCLC)的疗效和毒性.方法晚期NSCLC899例,用MVP方案31例,用EP方案58例,进行有效率和毒性的统计.结果MVP组有效率35.5%(11/31),EP组有效率31.0%(18/58),两组无显著性差异(P>0.05).两组剂量限制毒性均为骨髓抑制,白细胞下降占66.2%,Ⅲ~Ⅳ度下降MVP组为6.5%,EP组为6.7%.其次为胃肠道毒性和脱发,均为Ⅰ~Ⅱ度.结论MVP方案治疗晚期NSCLC的疗效和毒性与EP方案相仿,均为治疗晚期非小细胞肺癌安全有效的化疗方案.

关 键 词:非小细胞肺癌  联合化疗  长春地辛  
修稿时间:2003年3月18日

A Comparison of MVP Regimen Verus EP Regimen in the Treatment for Advanced Non - small Cell Lung Cancer
LIU Ying,BAO Huizheng,MA Lixia. Dep. of Chemotherapy of Tumor Hospital of Ji Lin Province,chang chun.A Comparison of MVP Regimen Verus EP Regimen in the Treatment for Advanced Non - small Cell Lung Cancer[J].Journal of Practical Oncology,2003,17(2):135-137.
Authors:LIU Ying  BAO Huizheng  MA Lixia Dep of Chemotherapy of Tumor Hospital of Ji Lin Province  chang chun
Institution:LIU Ying,BAO Huizheng,MA Lixia. Dep. of Chemotherapy of Tumor Hospital of Ji Lin Province,chang chun 130012
Abstract:Objective To compare the efficacy and toxicity in MVP and EP regimens for advanced non-small cell lung cancer. Methods The clinical data of 89 cases with advanced NSCLC treated with MVP regimen(31 cases) and EP regimen (58 cases) were analyzed. Results The response rate was 35.5% in patients treated with MVP, 31.0% in those treated with EP. The most common toxic reaction in two groups was myelosuppression. Conclusion MVP and EP are effective and safe chemotherapeutic projects for the treatment of advanced NSCLC patients.
Keywords:Non - small cell lung cancer  Combined chemotherapy  Vindesine
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《实用肿瘤学杂志》浏览原始摘要信息
点击此处可从《实用肿瘤学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号